{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:17:59Z","timestamp":1787807879000,"version":"build-2784847793"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001348","name":"A*STAR Research Entities","doi-asserted-by":"publisher","award":["H22J1a0050"],"award-info":[{"award-number":["H22J1a0050"]}],"id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001381","name":"National Research Foundation","doi-asserted-by":"publisher","award":["CRP27-2021-0038"],"award-info":[{"award-number":["CRP27-2021-0038"]}],"id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012415","name":"Biomedical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012415","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jconrel.2026.115136","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:33:25Z","timestamp":1782516805000},"page":"115136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Oligo(ethylene glycol)-functionalized polycarbonate lipid nanoparticles for mRNA delivery with attenuated PEG immunogenicity"],"prefix":"10.1016","volume":"397","author":[{"given":"Dao Thi Hong","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon Yi Loong","family":"Seow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithiyaa","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Hyun","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.P.","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115136_bb0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.115136_bb0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03275-y","article-title":"BNT162b vaccines protect rhesus macaques from SARS-CoV-2","volume":"592","author":"Vogel","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115136_bb0015","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115136_bb0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115136_bb0025","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115136_bb0030","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","article-title":"Global impact of the first year of COVID-19 vaccination: a mathematical modelling study","volume":"22","author":"Watson","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jconrel.2026.115136_bb0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41423-023-01095-w","article-title":"B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity","volume":"21","author":"Lapuente","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2026.115136_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.869990","article-title":"Long-lasting T cell responses in BNT162b2 COVID-19 mRNA vaccinees and COVID-19 convalescent patients","volume":"13","author":"Hurme","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115136_bb0045","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115136_bb0050","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1038\/s41591-022-02061-1","article-title":"The landscape of mRNA nanomedicine","volume":"28","author":"Huang","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.115136_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114990","article-title":"Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications","volume":"200","author":"Jeong","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115136_bb0060","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s12276-023-00999-x","article-title":"Knife\u2019s edge: balancing immunogenicity and reactogenicity in mRNA vaccines","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2026.115136_bb0065","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1016\/j.vaccine.2023.06.009","article-title":"Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: evidence for immunogenicity of PEG","volume":"41","author":"Kozma","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2026.115136_bb0070","doi-asserted-by":"crossref","first-page":"11485","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-PEG antibodies boosted in humans bySARS-CoV-2 lipid nanoparticle mRNA vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115136_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fbioe.2022.882363","article-title":"Understanding the role and impact of poly (ethylene glycol) (PEG) on nanoparticle formulation: implications for COVID-19 vaccines","volume":"10","author":"Pad\u00edn-gonz\u00e1lez","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115136_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102163","article-title":"Anti-PEG antibodies: current situation and countermeasures","volume":"55","author":"Fu","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.115136_bb0085","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jconrel.2007.05.015","article-title":"PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner","volume":"122","author":"Ishida","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115136_bb0090","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.imbio.2015.06.005","article-title":"Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells","volume":"220","author":"Shimizu","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.jconrel.2026.115136_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-024-00835-x","article-title":"Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines","volume":"9","author":"Bae","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jconrel.2026.115136_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202401712","article-title":"Cholesterol-derived Mannosylated polypeptide-formed lipid nanoparticles for efficient in vivo mRNA delivery","volume":"9","author":"Zeng","year":"2025","journal-title":"Small Methods"},{"key":"10.1016\/j.jconrel.2026.115136_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.mattod.2026.103389","article-title":"PEG immunogenicity-free LNPs targeting antigen-presenting cells enabling potent and safe H5N1 mRNA vaccination","volume":"98","author":"Zhao","year":"2026","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2026.115136_bb0110","article-title":"Polypeptide-engineered lipid nanoparticles for mRNA delivery with limited immunogenicity","author":"Zeng","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115136_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41563-025-02240-8","article-title":"Poly(carboxybetaine) lipids enhance mRNA therapeutics efficacy and reduce their immunogenicity","author":"Luozhong","year":"2025","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.115136_bb0120","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/s41563-024-02116-3","article-title":"High-density brush-shaped polymer lipids reduce anti-PEG antibody binding for repeated administration of mRNA therapeutics","volume":"24","author":"Xiao","year":"2025","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.115136_bb0125","doi-asserted-by":"crossref","first-page":"8646","DOI":"10.1021\/acsnano.8b04433","article-title":"Enhanced permeability and retention-like extravasation of nanoparticles from the vasculature into tuberculosis granulomas in zebrafish and mouse models","volume":"12","author":"Fenaroli","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115136_bb0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4049\/jimmunol.83.2.193","article-title":"Antigenicity of polypeptides (poly alpha amino acids)","volume":"83","author":"Maurer","year":"1959","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2026.115136_bb0135","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.1021\/acsanm.0c01834","article-title":"Polysarcosine-functionalized lipid nanoparticles for therapeutic mRNA delivery","volume":"3","author":"Nogueira","year":"2020","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.jconrel.2026.115136_bb0140","author":"Zhu"},{"key":"10.1016\/j.jconrel.2026.115136_bb0145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mabi.200700106","article-title":"Biodegradation of aliphatic and aromatic polycarbonates","volume":"8","author":"Artham","year":"2008","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2026.115136_bb0150","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/S0142-9612(00)00101-0","article-title":"Synthetic biodegradable polymers as orthopedic devices","volume":"21","author":"Middleton","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115136_bb0155","series-title":"Recent developments in biodegradable synthetic polymers","author":"Gunatillake","year":"2006"},{"key":"10.1016\/j.jconrel.2026.115136_bb0160","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1039\/B713925J","article-title":"Tagging alcohols with cyclic carbonate: a versatile equivalent of (meth)acrylate for ring-opening polymerization","volume":"2","author":"Pratt","year":"2008","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2026.115136_bb0165","doi-asserted-by":"crossref","first-page":"7863","DOI":"10.1021\/ma061607o","article-title":"Exploration, optimization, and application of supramolecular thiourea-amine catalysts for the synthesis of lactide (co)polymers","volume":"39","author":"Pratt","year":"2006","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2026.115136_bb0170","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1021\/acs.biomac.5c00088","article-title":"Replacing PEG-lipid with amphiphilic polycarbonates in mRNA-loaded lipid nanoparticles: impact of polycarbonate structure on physicochemical and transfection properties","volume":"26","author":"Le","year":"2025","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.115136_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.abj5305","article-title":"An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice","volume":"14","author":"Nanishi","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115136_bb0180","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2025.01.071","article-title":"Role of PEGylated lipid in lipid nanoparticle formulation for in vitro and in vivo delivery of mRNA vaccines","volume":"380","author":"Zhang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115136_bb0185","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/s41563-025-02383-8","article-title":"Designing around immune memory to counter PEG immunogenicity","volume":"24","author":"Chaudhary","year":"2025","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.115136_bb0190","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1021\/acsnano.1c05922","article-title":"Polyethylene glycol immunogenicity: theoretical, clinical, and practical aspects of anti-polyethylene glycol antibodies","volume":"15","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115136_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115136_bb0200","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1021\/acsbiomaterials.5b00551","article-title":"Critical length of PEG grafts on lPEI\/DNA nanoparticles for efficient in vivo delivery","volume":"2","author":"Williford","year":"2016","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.jconrel.2026.115136_bb0205","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.tips.2021.03.002","article-title":"The importance of apparent pKa in the development of nanoparticles encapsulating siRNA and mRNA","volume":"42","author":"Patel","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2026.115136_bb0210","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jconrel.2022.03.033","article-title":"Delivery of mRNA for regulating functions of immune cells","volume":"345","author":"Shi","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115136_bb0215","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115136_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120826","article-title":"Microfluidic formulation of nanoparticles for biomedical applications","volume":"274","author":"Shepherd","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.115136_bb0225","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115136_bb0230","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2016.05.059","article-title":"Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA","volume":"235","author":"Chen","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115136_bb0235","article-title":"Quantitative analysis of mRNA-lipid nanoparticle stability in human plasma and serum by size-exclusion chromatography coupled with dual-angle light scattering","volume":"58","author":"Liau","year":"2024","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.115136_bb0240","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejps.2005.08.002","article-title":"In vivo tumor targeting of tumor necrosis factor-\u03b1-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size","volume":"27","author":"Fang","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115136_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.02.055","article-title":"Investigating the stability of RNA-lipid nanoparticles in biological fluids: unveiling its crucial role for understanding LNP performance","volume":"381","author":"Zhang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115136_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.103041","article-title":"Biological recognition and cellular trafficking of targeted RNA-lipid nanoparticles","volume":"85","author":"Escalona-Rayo","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115136_bb0255","article-title":"Deciphering the biological fate of mRNA-LNP-based biologics: a perspective from tissue to intracellular distribution","author":"Xu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115136_bb0260","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1021\/acsptsci.4c00419","article-title":"PEGylation-dependent cell uptake of lipid nanoparticles revealed by spatiotemporal correlation spectroscopy","volume":"7","author":"Digiacomo","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.jconrel.2026.115136_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-14221-2","article-title":"A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery","volume":"7","author":"Wolfram","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115136_bb0270","article-title":"Design, optimization, and evaluation of lyophilized lipid nanoparticles for mRNA-based pulmonary mucosal vaccination","volume":"32","author":"Lu","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115136_bb0275","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-024-02812-x","article-title":"Role of size, surface charge, and PEGylated lipids of lipid nanoparticles (LNPs) on intramuscular delivery of mRNA","volume":"22","author":"Kong","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.115136_bb0280","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle \u2013 mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115136_bb0285","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal escape\u00a0: a bottleneck for LNP - mediated therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2026.115136_bb0290","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jconrel.2007.05.033","article-title":"Post-pegylated lipoplexes are promising vehicles for gene delivery in RPE cells","volume":"121","author":"Peeters","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115136_bb0295","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2818.2006.01706.x","article-title":"A guided tour into subcellular colocalization analysis in light","volume":"224","author":"Bolte","year":"2006","journal-title":"J. Microsc."},{"key":"10.1016\/j.jconrel.2026.115136_bb0300","first-page":"86","article-title":"Engineering LNPs with polysarcosine lipids for mRNA delivery","volume":"37","author":"Kang","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115136_bb0305","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1021\/acs.nanolett.8b00432","article-title":"A direct comparison of in vitro and in vivo nucleic acid delivery mediated by hundreds of nanoparticles reveals a weak correlation","volume":"18","author":"Paunovska","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115136_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17080950","article-title":"Formulation-driven optimization of PEG-lipid content in lipid nanoparticles for enhanced mRNA delivery in vitro and in vivo","volume":"17","author":"Liu","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115136_bb0315","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41578-019-0110-7","article-title":"Material design for lymph node drug delivery","volume":"4","author":"Schudel","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2026.115136_bb0320","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ddtec.2005.05.006","article-title":"Subcutaneous drug delivery and the role of the lymphatics","volume":"2","author":"McLennan","year":"2005","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.jconrel.2026.115136_bb0325","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41577-023-00897-3","article-title":"Memory B cells","volume":"24","author":"Inoue","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.115136_bb0330","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41565-023-01404-4","article-title":"Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines","volume":"18","author":"Han","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115136_bb0335","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/ni.2914","article-title":"CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype","volume":"15","author":"Zuccarino-Catania","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.115136_bb0340","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/hep.32572","article-title":"Liver injury after SARS-CoV-2 vaccination: features of immune-mediated hepatitis, role of corticosteroid therapy and outcome","volume":"76","author":"Efe","year":"2022","journal-title":"Hepatology"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926005390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926005390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:22:36Z","timestamp":1787804556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926005390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":68,"alternative-id":["S0168365926005390"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115136","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oligo(ethylene glycol)-functionalized polycarbonate lipid nanoparticles for mRNA delivery with attenuated PEG immunogenicity","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115136","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115136"}}